Heavy menstrual bleeding on direct factor Xa inhibitors: the MEDEA randomized clinical trial

Res Pract Thromb Haemost. 2024 May 20;8(4):102448. doi: 10.1016/j.rpth.2024.102448. eCollection 2024 May.

Eva N Hamulyák¹, Hanke M G Wiegers¹, Barbara A Hutten^{2

3}, Maria E de Lange⁴, Anne Timmermans⁴, Peter E Westerweel⁵, Marten R Nijziel⁶, Frederikus A Klok⁷, Marcel M Hovens⁸, Pieter W Kamphuisen^{1

9}, Harry R Büller¹, Saskia Middeldorp^{1

10}, Luuk J J Scheres^{10

11}

¹ Department of Vascular Medicine, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.
² Department of Epidemiology and Data Science, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.
³ Amsterdam Cardiovascular Sciences Research Institute, Diabetes & Metabolism, Amsterdam, The Netherlands.
⁴ Department of Gynecology and Obstetrics, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.
⁵ Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, The Netherlands.
⁶ Department of Hematology, Catharina Hospital Eindhoven, Eindhoven, The Netherlands.
⁷ Department of Medicine - Thrombosis and Haemostasis, Leiden University Medical Center, Leiden, The Netherlands.
⁸ Department of Internal Medicine, Rijnstate Hospital, Arnhem, The Netherlands.
⁹ Department of Internal Medicine, Tergooi Hospital, Hilversum, The Netherlands.
¹⁰ Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
¹¹ Department of Clinical Epidemiology, Leiden, University Medical Center, Leiden, The Netherlands.

No abstract available